GAVISCON EXTRA STRENGTH peppermint oral liquid bottle

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

sodium alginate, Quantity: 100 mg/mL; potassium bicarbonate, Quantity: 20 mg/mL; calcium carbonate, Quantity: 20 mg/mL

Commercializzato da:

Reckitt Benckiser Pty Ltd

Forma farmaceutica:

Oral Liquid, suspension

Composizione:

Excipient Ingredients: propyl hydroxybenzoate; saccharin sodium; methyl hydroxybenzoate; purified water; carbomer 934P; sodium hydroxide; Flavour

Via di somministrazione:

Oral

Confezione:

300mL, 140mL, 500mL, 250mL

Tipo di ricetta:

Not scheduled. Not considered by committee

Indicazioni terapeutiche:

For the relief of the symptoms associated with reflux oesophagitis, hiatus hernia and all cases of epigastric distress where the underlying cause is gastro-oesophageal reflux.

Dettagli prodotto:

Visual Identification: Off-white suspension; Container Type: Bottle; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2020-10-21